AGC Biologics, Molecular Partners develop COVID-19 protein therapy

By The Science Advisory Board staff writers

July 9, 2020 -- AGC Biologics has partnered with clinical-stage biotechnology company Molecular Partners to create a protein therapy against SARS-CoV-2, the virus that causes COVID-19.

The new class of custom-built protein therapies, called Darpin, has antiviral effects. The companies will work together to develop MP0420, a multispecific Darpin anti-COVID-19 program. MP0420 has demonstrated therapeutic effects for existing COVID-19 viral infection in preliminary data, the companies noted.

Through the partnership, AGC Biologics will manufacture MP0420 in 100 liter and 1,000-liter scales. Molecular Partners AG plans to conduct clinical studies using the manufactured protein therapeutics later this year.

AGC Biologics expands plasmid manufacturing capacity
AGC Biologics is expanding its plasmid DNA Center of Excellence in Heidelberg, Germany, to meet the need for process development and manufacturing of...
Saiba selects AGC to manufacture COVID-19 vaccine
Contract development and manufacturing organization AGC Biologics said it will be manufacturing a SARS-CoV-2 vaccine for Swiss biotechnology firm Saiba.
AGC to manufacture adjuvant for Novavax COVID-19 vaccine
AGC Biologics announced it is partnering with Novavax for large-scale good manufacturing practices production of critical components for Novavax's coronavirus...
AGC acquires commercial manufacturing facility
Contract development and manufacturing organization AGC Biologics has purchased a large-scale biopharmaceutical manufacturing facility in Boulder, CO.
AGC to manufacture Takara Bio's COVID-19 vaccine
In the fight against COVID-19, AGC Biologics, a contract development and manufacturing organization, is partnering with Takara Bio to manufacture plasmid...

Copyright © 2020

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter